Contract notice
Section I: Contracting
authority
I.1) Name and addresses
Leeds Teaching Hospitals NHS Trust (on behalf of The Collaborative-see below)
Supplies Dept, St James Hospial, Trust HQ, Beckett St
Leeds
LS9 7TF
UK
Contact person: Mr John Smith
E-mail: j.smith115@nhs.net
NUTS: UK
Internet address(es)
Main address: http://www.leedsteachinghospitals.com/
Address of the buyer profile: http://www.leedsteachinghospitals.com/
I.1) Name and addresses
Mid Yorkshire Hospitals NHS Trust
Wakefield
UK
E-mail: j.smith115@nhs.net
NUTS: UK
Internet address(es)
Main address: www.midyorks.nhs.uk
I.1) Name and addresses
Calderdale and Huddersfield NHS Foundation Trust
Huddersfield
UK
E-mail: j.smith115@nhs.net
NUTS: UK
Internet address(es)
Main address: www.cht.nhs.uk
I.2) Joint procurement
The contract involves joint procurement
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://procontract.due-north.com/Login
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://procontract.due-north.com/Login
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Collaborative Pathology Managed Service Contract on behalf of Calderdale and Huddersfield NHS Foundation Trust, Leeds Teaching Hospitals NHS Trust and Mid Yorkshire NHS Trust
Reference number: DN501953
II.1.2) Main CPV code
85111800
II.1.3) Type of contract
Services
II.1.4) Short description
Calderdale and Huddersfield NHS Foundation Trust (CHFT), Leeds Teaching Hospitals NHS Trust (LTHT) and The Mid Yorkshire Hospitals NHS Trust (MYHT) (The “Collaborative”) are undertaking a competitive dialogue procurement exercise to select a managed service provider to supply The Collaborative’s Pan Pathology Managed Service (lot 1) and Cellular Pathology (lot 2). The provider for lot 2 may be the same provider or a different provider.
The procurement exercise is intended to result in a managed service which provides a flexible, quality and patient focused innovative service in line with best practice ensuring The Collaborative meets the needs of its patients.
The Collaborative wants to partner with a managed service provider to:
• underpin the ambition of The Collaborative as an exemplar Pathology Service now and in the future
• keep pace and evolve with the rapidly changing dynamics of delivering Pathology Services
The procurement exercise is intended to find a provider who will:
• Provide a state-of-the-art solution which can support the requirements today and in the future ensuring there is flexibility to adopt innovative solutions during the term of the contract;
• Provide a solution that meets the quality and speed of testing required by our patients and clinicians and which meets local and national turnaround times;
• Deploy and expand Point of Care testing in hospitals and primary care and self-testing at home;
• Facilitate cross site working and consistent processes to allow flexibility across The Collaborative;
• Support the transformational plans across the trusts, offering the flexibility of solution to support any consolidation of testing between laboratories;
• Work with a provider of Cellular pathology (lot 2) (which may be the same provider or a different provider).
The intended outcome of the procurement exercise is to contract with a provider who agrees to the contract evolving during its life. This will require on-going assessment, implementation of innovative changes and collaborative working with the provider and potential sub-contractors over the life of the contract. The way the service looks at the end of the contract will likely be very different to the initial implementation. Further details as to the contract structure for lot 1 and 2, as well as potential future services are set out in the Descriptive Document.
II.1.5) Estimated total value
Value excluding VAT:
475 000 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
Yes
Tenders may be submitted for all lots
II.2) Description
Lot No: 1
II.2.1) Title
Lot 1 Blood Sciences, Specialist Testing, Microbiology, Automation and Programme Management
II.2.2) Additional CPV code(s)
85111800
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
Blood Sciences, Specialist Testing, Microbiology, Automation and Programme Management
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
427 000 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 168
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
Envisaged number of candidates: 5
Objective criteria for choosing the limited number of candidates:
As set out in the Selection Questionnaire
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Cellular Pathology
II.2.2) Additional CPV code(s)
85111800
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
Cellular Pathology
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
48 000 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 168
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
Envisaged number of candidates: 5
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Competitive dialogue
IV.1.4) Information about reduction of the number of solutions or tenders during negotiation or dialogue
Recourse to staged procedure to gradually reduce the number of solutions to be discussed or tenders to be negotiated
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2020/S 193-467869
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
20/10/2021
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 12 (from the date stated for receipt of tender)
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
High Court - As per Public Contract Regulations 2015
London
UK
VI.5) Date of dispatch of this notice
21/09/2021